Director/PDMR Shareholding

EMV Capital

04/06/2025 14:34

RNS Number : 4650L

EMV Capital PLC

04 June 2025

 

EMV Capital plc

 

("EMV Capital" or the "Company")

 

Director/PDMR Shareholding

 

EMV Capital plc (AIM: EMVC), the deeptech and life sciences VC investment group, announces that on 4 June 2025, Dr Ilian Iliev (Chief Executive Officer) and Ed Hooper (Executive Director) purchased in aggregate 52,516 ordinary shares in the capital of EMV Capital plc ("Ordinary Shares") through their respective Self-Invested Personal Pensions.

 

Following such purchases Dr Iliev and Mr Hooper holds Ordinary Shares as summarised below:

 

Name
New Ordinary Shares
Total number of Ordinary Shares
Toal percentage of entire issued Ordinary Shares
Dr Ilian Iliev
24,516
3,885,973
13.99%
Ed Hooper
28,000
330,000
1.19%

 

The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr Ilian Iliev
2
Reason for the notification
a)
Position/status
Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
EMV Capital plc
b)
LEI
213800N5WD46G1Y7I458
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
EMVC 5p Ordinary Shares
GB00BN4R5Q82
b)
Nature of the transaction
Purchase of Ordinary Shares into SIPP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.4074
24,516 shares
d)
Aggregated information
- Aggregated volume
- Price
N/a
e)
Date of the transaction
4 June 2025
f)
Place of the transaction
UK AIM

 

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Ed Hooper
2
Reason for the notification
a)
Position/status
Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
EMV Capital plc
b)
LEI
213800N5WD46G1Y7I458
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
EMVC 5p Ordinary Shares
GB00BN4R5Q82
b)
Nature of the transaction
Purchase of Ordinary Shares into SIPP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.3788
10,528 shares
£0.3788
10,528 shares
£0.399
6,944 shares
d)
Aggregated information
- Aggregated volume
- Price
28,000
£0.38381
e)
Date of the transaction
4 June 2025
f)
Place of the transaction
UK AIM

 

#  #  #

 

For more information, please contact:
EMV Capital plc
via Rosewood
Ilian Iliev, CEO
Panmure Liberum Limited(NOMAD and Broker)
+44 (0)20 7886 2500
Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance)
Rupert Dearden (Corporate Broking)
Rosewood(Financial PR)
+44 (0)20 7653 8702
John West /Llewellyn Angus / Lily Pearce


 

About EMV Capital plc (EMVC)

EMV Capital plc is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies.

 

With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future; EMV Capital invests in, manages and strengthens early stage IP-rich companies.

 

EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. EMV Capital's investment thesis is realised through these capital sources:

 

·     capital-efficient investments through Group balance sheet;

·     fund management of the Evergreen EIS and Martlet Capital Funds;

·     syndicated investments leveraging its network of third-party investors.

 

EMV Capital's approach is characterised by its proactive management style, aiming to advance portfolio companies to critical value inflection points by actively engaging with them. Companies are supported through Board representation and the use of its Value Creation Services practice.

 

Headquartered in London, with a Cambridge presence and strong international links, EMV Capital is quoted on the AIM market of the London Stock Exchange.

 

www.emvcapital.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHUSOORVOUNRAR